Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
In the present study, we analyzed the interaction of concomitantly-acting pairs of opioid agonists in inhibiting the electrically induced contraction of the rat vas deferens (RVD). The results when compared with the predictions of the law of mass action and the receptor theory (1,2) provide evidence for a specific receptor for beta-endorphin (beta-EP) in this organ. This receptor is not occupied by the delta-agonist D-Ala2-D-Leu5-enkephalin (DADLE), or the mu-agonists Sandoz FK-33824, fentanyl and etorphine in the range of concentrations necessary for these to exert their maximal agonistic action in the test. The activity of beta-endorphin in the rat vas deferens is in agreement with the proposed existence (3,4) of the epsilon-type of opioid receptor therein.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/0143-4179(84)90037-4 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!